Quarterly report [Sections 13 or 15(d)]

Share-Based Compensation

v3.25.2
Share-Based Compensation
6 Months Ended
Jun. 30, 2025
Share-Based Compensation.  
Share-Based Compensation

10. SHARE-BASED COMPENSATION

Effective July 1, 2015, our eligible employees commenced participation in the 2015 LTIP. The 2015 LTIP authorized the Board to grant stock options, stock appreciation rights, restricted shares, restricted share units, performance awards, and dividend equivalents. All grants were made by issuing new shares and no more than 4.0 million shares of common stock may be issued under the 2015 LTIP.

On February 18, 2025, the Board of Directors adopted the 2025 LTIP. Shares of our common stock remaining available for awards under the previous 2015 LTIP will continue to be authorized for future awards under the 2025 LTIP. As of June 30, 2025, we had 1.7 million shares remaining available for issuance under the 2025 LTIP.

Share-based compensation expense is included in selling, general, and administrative expense. The income tax effect associated with share-based compensation awards is included in income tax expense.  

The following table presents share-based compensation amounts recognized in our condensed consolidated statements of operations, in thousands:

Three Months Ended June 30, 

Six Months Ended June 30, 

2025

2024

2025

2024

Share-based compensation expense

$

4,764

$

4,632

$

9,806

$

9,759

Income tax benefit/(expense)

$

112

$

(98)

$

(549)

$

(2,107)

The following table presents a summary of our share-based compensation activity for the six months ended June 30, 2025, in thousands, except per share amounts:

RSAs

Stock Options

Number of Shares

   

Weighted Average Grant Date Fair Value Per Share

   

Number of Shares

   

Weighted Average Grant Date Fair Value Per Share

   

Weighted Average Exercise Price Per Share

   

Aggregate
Intrinsic
Value

Balance December 31, 2024

176.0

$

269.50

112.7

$

30.10

$

83.97

$

25,604.9

Granted

55.9

$

339.97

Converted/Exercised

(56.6)

$

240.45

Forfeited/Expired

(14.7)

$

298.21

Balance June 30, 2025

160.6

$

301.62

112.7

$

30.10

$

83.97

$

27,001.3

Exercisable June 30, 2025 (a)

112.7

$

30.10

$

83.97

$

27,001.3

(a) The weighted average remaining contractual term for vested stock options is approximately 3.7 years.

We have unrecognized share-based compensation expense related to unvested awards as shown in the following table, dollars in thousands:

As of June 30, 2025

Unrecognized Compensation Expense
on Unvested Awards

Weighted Average
Remaining
Compensation Expense Period

RSAs

$

27,167

1.1

Stock options

Total unrecognized compensation expense related to unvested awards

$

27,167

Our RSAs with performance-based conditions are evaluated on a quarterly basis with adjustments to compensation expense based on the likelihood of the performance target being achieved or exceeded. The following table shows the range of payouts and the related expense for our outstanding RSAs with performance-based conditions, in thousands:

Payout Ranges and Related Expense

RSAs with Performance-Based Conditions

Grant Date Fair Value

0%

25%

100%

200%

February 21, 2023

$

3,780

$

-

$

945

$

3,780

$

7,560

February 21, 2024

$

4,370

$

-

$

1,093

$

4,370

$

8,740

February 18, 2025

$

4,994

$

-

$

1,249

$

4,994

$

9,988

During the first quarter of 2025, RSAs with performance-based conditions that were granted on February 15, 2022 vested based on cumulative three-year achievement of 200%. Total compensation expense recognized over the three-year performance period, net of forfeitures, was $5.8 million.

The fair value of our RSAs with a market-based condition granted under the 2015 LTIP was determined using a Monte Carlo simulation. The following are key inputs in the Monte Carlo analysis for awards granted in 2025, 2024, and 2023:

2025

2024

2023

Measurement period (years)

2.86

2.86

2.86

Risk free interest rate

4.28

%

4.36

%

4.42

%

Dividend yield

0.00

%

0.00

%

0.00

%

Estimated fair value of market-based RSAs at grant date

$

393.39

$

503.68

$

270.64